Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia

Journal of Acquired Immune Deficiency Syndromes

Volumn 7, Issue 5, 1994, Pages 474-484

  Revicki, Dennis A ^a   Brown, Ruth E ^a   Henry, David H ^b   McNeill, Michele V ^c   Rios, Adan ^d   Watson, Terry ^e  

^a BATTELLE MEMORIAL INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Kern McNeill International ^*  (United States)

^d OnCoI Medical Associates ^*  (United States)

^e Private Practice   (United States)

Author keywords

AIDS; Anemia; Erythropoietin; Health related quality of life; Recombinant human erythropoietin

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALERTNESS; ANEMIA; ARTICLE; CLINICAL TRIAL; COGNITION; DRUG SAFETY; ENERGY; FATIGUE; FEMALE; HEADACHE; HEMATOCRIT; HUMAN; HYPERTENSION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RASH; SEIZURE; SOCIAL INTERACTION; SUBCUTANEOUS DRUG ADMINISTRATION; TASK PERFORMANCE; TRANSFUSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANEMIA; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEMATOCRIT; HUMAN; INJECTIONS, SUBCUTANEOUS; MALE; QUALITY OF LIFE; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0028210192     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Revicki DA, Rothman M, Luce BR. Health-related quality of life assessment and the pharmaceutical industry. Pharmacoeconomics 1992;1:394-408.
2. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 1990;3:683-90.
3. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study : preliminary validation in persons with early HIV infection. Med Cure 1991;29:786-98.
4. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. New Engl J Med 1987; 317:185-91.
5. Smiley L. AZT Collaborative Group. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long term experience. J Infect 1989;18(Suppl 1):1-77.
6. Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med 1987;317:192-7.
7. Walker RE, Parker RI, Kovacs JA, et al. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med 1988;108:372-6.
8. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine. JAMA 1988;260:3009-15.
9. Cohen H, Williams F, Matthey RF, et al. Reversible zidovudine-induced pure red-cell aplasia. AIDS 1989;3:177-8.
10. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-92.
11. Koch MA, Volberding PA, Lagakos SW, et al. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 ×109/L or less. Arch Intern Med 1992;152:2286-92.
12. Phair JP, Abels RI, McNeill MV, Sullivan DJ. Recombinant human erythropoietin treatment investigational new drug protocol for the anemia of acquired immunodeficiency syndrome. Overall results. Arch Intern Med 1993;153:2669-75.
13. Henry DH, Beall GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of the anemia associated with human immunodeficiency virus infection and zidovudine therapy: overview of four clinical trials. Ann Intern Med 1992;117:739-48.
14. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br Med J 1990;300:573-8.
15. Eshbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. New Engl J Med 1987; 316:73-8.
16. Lim VS, DeGowin RL, Zavala D, et al. Recombinant human erythropoietin treatment in pre-dialysis patients. Ann Intern Med 1989;110:108-14.
17. Eshbach JW, Kelly MR, Haley NR, Abels RL, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. New Engl J Med 1989; 321:158-63.
18. Evans RW, Rader B, Manninen DL. Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 1990;263:825-30.
19. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Cure 1981;19:787-805.
20. Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nursing Res 1990;39:355-9.
21. Stewart AL, Hays RD, Ware JE Jr. The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Cure 1988;26:724-35
22. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA 1989;262:907-13.
23. Stewart AL, Ware JE Jr, eds. Measuring functioning and well-being: the medical outcomes study approach. Durham. NC: Duke Univ. Press. 1992.
24. Campbell A, Converse PE, Rogers WL. The quality of American life. New York: Russell Sage Foundation. 1976.
25. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appi Psychol Measurement 1977; 1:385-401.
26. Ostrow DG, Monjan A, Joseph J, et al. HIV-related symptoms and psychological functioning in a cohort of homosexual men. Am J Psychiatry 1989;146:737-42.
27. Wachtel T, Piette J, Mor V, et al. Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Ann Intern Med 1992;116:129-37.
28. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992;1:359-66.
29. Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: a community-based study. Med Care 1993;31:269-76.